Insider · CIK 0001095168
Peter C Brown
Files at EPR (EPR PROPERTIES), CNVS (Cineverse Corp.). First filing Dec 26, 2023, latest Dec 26, 2023.
In brief
Peter C Brown files SEC Form 4 as director at EPR (EPR PROPERTIES), and also at CNVS (Cineverse Corp.). Since Dec 26, 2023, Peter C Brown has reported 0 open-market buys worth $0 and 1 open-market sell worth $122k, the latest filed on Dec 26, 2023.
A track record needs three past buys with six months of prices behind them; Peter C Brown has 0, so none is measured yet.
The newest scored trade: sold $122k of EPR on Dec 22, 2023, filed Dec 26, 2023, scored 38 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EPR: EPR PROPERTIES
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | EPR PROPERTIES | $122k 2,500 shares | -12% | +49% from low-0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 22, 2023 | EPR EPR PROPERTIES | 2,500 0.00% of outstanding | $121k | Dec 22, 2023 | none |
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | EPR EPR PROPERTIES | MOption exercise Common Shares of Beneficial Interest | +3,518 | - | - | 31,193 | Jun 2, 2026 |
| Jun 1, 2026 | EPR EPR PROPERTIES | MOption exercise Restricted Share Unitsderivative | -3,518 | $0.00 | $0 | 0 | Jun 2, 2026 |
| Jun 1, 2026 | EPR EPR PROPERTIES | AGrant or award Restricted Share Unitsderivative | +2,358 | $0.00 | $0 | 2,358 | Jun 2, 2026 |
| Jun 1, 2026 | EPR EPR PROPERTIES | AGrant or award Restricted Share Unitsderivative | +1,048 | $0.00 | $0 | 3,406 | Jun 2, 2026 |
| Dec 8, 2025 | CNVS Cineverse Corp. | AGrant or award Class A Common Stock | +32,413 | $0.00 | $0 | 160,361 | Dec 12, 2025 |
| Jun 2, 2025 | EPR EPR PROPERTIES | MOption exercise Common Shares of Beneficial Interest | +4,774 | - | - | 27,675 | Jun 4, 2025 |
| Jun 2, 2025 | EPR EPR PROPERTIES | MOption exercise Restricted Share Unitsderivative | -4,774 | $0.00 | $0 | 0 | Jun 4, 2025 |
| Jun 2, 2025 | EPR EPR PROPERTIES | AGrant or award Restricted Share Unitsderivative | +2,506 | $0.00 | $0 | 2,506 | Jun 4, 2025 |
| Jun 2, 2025 | EPR EPR PROPERTIES | AGrant or award Restricted Share Unitsderivative | +1,012 | $0.00 | $0 | 3,518 | Jun 4, 2025 |
| Jan 3, 2025 | CNVS Cineverse Corp. | AGrant or award Class A Common Stock | +24,433 | $0.00 | $0 | 127,948 | Jan 7, 2025 |
| Dec 22, 2023 | EPR EPR PROPERTIES | SOpen-market sale Common Shares | -2,500 | $48.68 | $122k | 18,094 | Dec 26, 2023 |
| Dec 8, 2023 | CNVS Cineverse Corp. | AGrant or award Class A Common Stock | +80,372 | $0.00 | $0 | 543,241 | Dec 12, 2023 |
Questions about Peter C Brown
Answered from the filings on this page, as of the latest one.
Is Peter C Brown buying or selling?
Not in the last 12 months. Peter C Brown's latest open-market trade on SEC Form 4 was sold $122k of EPR on Dec 22, 2023.
How did Peter C Brown's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter C Brown has 0.
Where does Peter C Brown file Form 4?
Peter C Brown has filed Form 4 at EPR (EPR PROPERTIES); CNVS (Cineverse Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.